Starling Oncology, Inc. ($STLN)
Filing Information
| Accession Number | 0000921895-26-002203 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 17, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
12,100
Total Value
$79,104.00
P&L
-6.3% ($4,920.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock | โ | Aug 14, 2026 | Purchase | 12,000 | $6.54 | $78,480.00 | 10,660,858 | Direct | โ | View Details | |
10% Owner | Call Option (STLN 19FEB27 $9C) | Derivative | Aug 13, 2026 | Sale | 100 | $6.24 | $624.00 | 0 | Direct | โ | View Details |